SCHEMBL20179247

SCHEMBL20179247

CCOC(=O)c1ccc(CC(C=O)CCC(=O)NOCc2oc(=O)oc2C)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.61
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 2/20 0.36
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA12 O43570 1/20 0.34
ESR1 P03372 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
ESR2 Q92731 1/20 0.34
CA14 Q9ULX7 1/20 0.34
MAPT P10636 7/20 0.34
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
KDM4E B2RXH2 1/20 0.34
HSP90AA1 P07900 1/20 0.34
LMNA P02545 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26038808 0.90 FOLH1 (0.76) FOLH1NPC1RAB9A
SCHEMBL21577992 0.88 FOLH1 (0.65) FOLH1SMN1; SMN2HTTCA1CA2
SCHEMBL20179142 0.87 FOLH1 (0.72) FOLH1SMN1; SMN2HTTCA1CA2
SCHEMBL20179133 0.86 FOLH1 (0.82) FOLH1SMN1; SMN2HTTCA1CA2
SCHEMBL20168739 0.83 FOLH1 (0.66) FOLH1SMN1; SMN2HTTCA1CA2
SCHEMBL21578141 0.77 FOLH1 (0.62) FOLH1CA1CA2CA12CA9
SCHEMBL21577914 0.77 FOLH1 (0.80) FOLH1NPC1RAB9AGAA
SCHEMBL21570573 0.74 FOLH1 (0.80) FOLH1CA2CA9
SCHEMBL26039286 0.74 FOLH1 (0.63) FOLH1
SCHEMBL21578051 0.73 FOLH1 (0.75) FOLH1KDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154939-A2 GCPII INHIBITION FOR THE TREATMENT OF SARCOPENIA AND AGING THE JOHNS HOPKINS UNIVERSITY (US) 2023-08-17 WO disclosed
WO-2018094334-A1 PRODRUGS OF HYDROXAMATE-BASED GCPII INHIBITORS THE JOHNS HOPKINS UNIVERSITY (US) 2018-05-24 WO disclosed